Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Maravai Lifesciences Holdings, Inc. (MRVI)  
$8.89 0.04 (0.45%) as of 4:30 Thu 5/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 138,800,000
Market Cap: 1.23(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.7 - $14.64
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Maravai is a holding company. Through its subsidiaries, Co. operates as a life sciences company that provides products to enable the development of drug, therapies, diagnostics, vaccines, and support research on human diseases. Co. operates in two segments: Nucleic Acid Production, which includes messenger ribonucleic acid, long and short oligonucleotides, its CleanCap® capping technology and oligonucleotide building blocks; and Biologics Safety Testing, which sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 120
  Page 1 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gtcr Partners Xi/b Lp   –       •       •   2024-05-28 4 S $9.82 $97,570,660 I/I (9,940,974) 20,150,005     -
   Gtcr Partners Xi/b Lp   –       •       •   2024-05-28 4 A $0.00 $0 I/I 8,409,946 30,090,979     -
   Gtcr Partners Xi/b Lp   –       •       •   2024-05-28 4 D $0.00 $0 I/I (8,409,946) 110,684,080     -
   Lucier Gregory T Director   –       •      –    2024-05-23 4 A $10.78 $222,553 D/D 20,645 75,768     -
   Mihas Constantine S Director   –       •      –    2024-05-23 4 A $10.78 $222,553 D/D 20,645 48,916     -
   Hopfield Jessica Director   –       •      –    2024-05-23 4 A $10.78 $222,553 D/D 20,645 110,768     -
   Cunningham Sean Laurence Director   –       •      –    2024-05-23 4 A $10.78 $222,553 D/D 20,645 48,916     -
   Ashkenazi Anat Director   –       •      –    2024-05-23 4 A $10.78 $222,553 D/D 20,645 60,768     -
   Prahalad Murali Director   –       •      –    2024-05-23 4 A $10.78 $222,553 D/D 20,645 65,468     -
   Marker Luke Joseph Director   –       •      –    2024-05-23 4 A $10.78 $222,553 D/D 20,645 48,916     -
   Daverman Benjamin James Director   –       •      –    2024-05-23 4 A $10.78 $222,553 D/D 20,645 48,916     -
   Deford John A Director   –       •      –    2024-05-23 4 A $10.78 $222,553 D/D 20,645 52,546     -
   Gray Susannah Director   –       •      –    2024-05-23 4 A $10.78 $222,553 D/D 20,645 80,768     -
   Leddy Peter Michael See Remarks   •       –      –    2024-04-30 4 A $5.70 $26,083 D/D 4,576 380,935     -
   Burch Andrew See Remarks   •       –      –    2024-04-30 4 A $5.70 $9,798 D/D 1,719 421,754     -
   Oreshack Kurt General Counsel   •       –      –    2024-04-30 4 A $5.70 $1,944 D/D 341 223,690     -
   Herde Kevin Chief Financial Officer   •       –      –    2024-04-30 4 A $5.70 $10,146 D/D 1,780 334,694     -
   Dolan Christine See Remarks   •       –      –    2024-04-30 4 A $5.70 $2,753 D/D 483 258,490     -
   Burch Andrew See Remarks   •       –      –    2024-04-15 4 D $8.11 $135,907 D/D (16,758) 420,035     -
   Dolan Christine See Remarks   •       –      –    2024-03-15 4 D $7.70 $41,449 D/D (5,383) 258,007     -
   Buzzeo Rebecca See Remarks   •       –      –    2024-03-15 4 D $7.70 $33,618 D/D (4,366) 365,066     -
   Hull Carl See Remarks   •       •      –    2024-03-15 4 D $7.70 $135,212 D/D (17,560) 267,072     -
   Leddy Peter Michael See Remarks   •       –      –    2024-03-15 4 D $7.70 $51,698 D/D (6,714) 376,359     -
   Herde Kevin Chief Financial Officer   •       –      –    2024-03-15 4 D $7.70 $66,405 D/D (8,624) 332,914     -
   Oreshack Kurt General Counsel   •       –      –    2024-03-15 4 D $7.70 $35,043 D/D (4,551) 223,349     -
  120 Records found
  1  2  3  4  5   
  Page 1 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us